Loading provider…
Loading provider…
Neurology Physician in Nashville, TN
NPI: 1164435004Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD Ryan's Phone Numberphone_androidMobile
Get MD Ryan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
TN State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 148 | 204 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 40 | 68 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 13 | 15 |
Blood pressure fluctuations in posterior reversible encephalopathy syndrome.
Authors: Rabinstein, Alejandro A, Mandrekar, Jay, Merrell, Ryan, Kozak, Osman S, Durosaro, Olayemi, Fugate, Jennifer E
Journal: J Stroke Cerebrovasc Dis
Publication Date: 2011-05-04
Authors: Daniel Lachance, Francis Ali-Osman, Elizabeth Claus, Rose Lai
Journal: Cancer Epidemiol Biomarkers Prev
Authors: Priya Kumthekar, Rimas Lukas, Bakhtiar Yamini, Karan Dixit, Steven Chmura, Roger Stupp
Journal: Neurooncol Adv
Publication Date: 2024-02-01
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, DRUG: Veliparib, OTHER: Placebo Administration
Lead Sponsor: Precision Life Sciences Group
Collaborators: Medelis Inc.
Intervention / Treatment: BIOLOGICAL: Placebo, BIOLOGICAL: ICT-107
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab